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Human Rad9 is a key cell-cycle checkpoint protein that is postulated to function in 
the early phase of cell-cycle checkpoint control through complex formation with Rad1 
and Hus1. Rad9 is also thought to be involved in controlling apoptosis through its 
interaction with Bcl-2. To explore the biochemical functions of Rad9 in these cellular 
control mechanisms, we performed two-hybrid screening and identified 
Tetratricopeptide repeat protein 2 (Tpr2) as a novel Rad9-binding protein. We found that 
Tpr2 binds not only to Rad9, but also to Rad1 and Hus1, through its N-terminal 
tetratricopeptide repeat region, as assessed by in vivo and in vitro binding assays. 
However, the in vivo and in vitro interactions of Tpr2 with Rad9 were greatly enhanced 
by the deletion of its C-terminal J domain or by a point mutation in the conserved HPD 
motif in the J domain, though the binding of Tpr2 to Rad1 and Hus1 was not influenced 
by these J-domain mutations. We further found; (1) Rad9 transiently dissociates from 
Tpr2 following heat-shock or UV treatments, but the mutation of the J domain abrogates 
this transient dissociation of the Tpr2/Rad9 complex; and (2) the J domain of Tpr2 
modulates the cellular localization of both Tpr2 itself and Rad9. These results indicate 
that the J domain of Tpr2 plays a critical role in the regulation of both physical and 
functional interactions between Tpr2 and Rad9. 
 
Key Words: cell cycle checkpoint, apoptosis, chaperone, tetratricopeptide repeat, J 
domain, Rad9, Hus1, Rad1 
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Introduction 
Cell-cycle checkpoints are surveillance mechanisms that monitor the cell cycle and 
protect genome integrity by inducing cell-cycle arrest or programmed cell death 
(apoptosis) in response to DNA damage or DNA replication errors. Because several 
features of cell cycle checkpoints have been conserved throughout evolution, 
information about cell cycle checkpoints learned from yeast provides a framework for 
developing a further understanding of the checkpoint pathways in higher eukaryotes (1, 
2). Genetic studies in the fission yeast S. pombe have identified three key checkpoint 
molecules (Rad1+, Hus1+, and Rad9+) (3-5) and mammalian homologs of these 
molecules have been identified (6-8). These checkpoint molecules show some 
homology with nucleases (9, 10) and proliferating cell nuclear antigen (PCNA), and are 
thought to function in the early phase of the cell-cycle checkpoint pathway as a part of a 
checkpoint protein complex (11-13). Of these checkpoint molecules, Rad9 may have an 
additional unique function, because it contains a 15-amino-acid region near its 
N-terminus that is significantly homologous to the BH3 domains conserved among 
many of the apoptotic Bcl-2 family (14-16). To study the biochemical functions of 
mammalian Rad9 as both a checkpoint and a possible apoptotic molecule, we used a 
yeast two-hybrid method with full-length human Rad9 as bait, and identified Tpr2 
(Tetratricopeptide repeat protein 2) as a novel Rad9-binding factor.  
Tpr2 was first identified as a factor interacting with the GAP-related domain of 
neurofibromin in two-hybrid screening, and is a member of the growing Tpr family (17). 
All members of this family contain various numbers of a degenerate 34-amino-acid 
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repeated motif called a tetratricopeptide repeat (tpr). The tpr’s are protein-protein 
interacting motifs, and function in diverse cellular processes such as cell-cycle control, 
transcription repression, stress response, protein kinase inhibition, mitochondrial and 
peroxisomal protein transport, and neurogenesis (18, 19). Tpr2 contains seven tpr motifs 
in its N-terminus and has been reported to bind Hsc70 through these tpr motifs (20). In 
addition, in its C-terminus, Tpr2 has a typical J domain found among members of the 
Hsp40/DnaJ co-chaperone family (21). The Hsp40/DnaJ family members regulate the 
chaperone activity of Hsp70/Hsc70 by stimulating their intrinsic ATPase activity; 
therefore, it is plausible that Tpr2 also functions as a co-chaperone in various cellular 
processes. Indeed, Tpr2, together with Hsp40, has been identified as a suppressor of 
polyglutamine-mediated degeneration in a Drosophila experimental system (22). In 
addition, p58, the most closely related homolog of Tpr2 in the Tpr family, has been 
characterized as a physiological inhibitor of dsRNA-dependent protein kinase (PKR), a 
primary mediator of the antiviral and antiproliferative properties of interferon (23). 
More recently, p58 has been shown to inhibit the apoptosis induced by PKR and the 
inflammatory cytokine TNF-α (24). However, the precise cellular functions of Tpr2 
remain to be clarified. 
In the present study, we show that Tpr2 binds not only to Rad9, but also to Rad1 and 
Hus1, in vivo. However, unlike the interactions of Tpr2 with Rad1 or Hus1, both the in 
vivo Tpr2/Rad9 interaction and the cellular localization of Rad9 are influenced by the J 
domain of Tpr2. These results indicate a critical role for the J-domain of Tpr2 in 
functional interactions between Tpr2 and Rad9. The possible physiological significance 
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of this finding is discussed. 
 
Experimental Procedures 
Yeast two-hybrid screening. Total RNA was isolated from MCF7 cells using 
TRIZOL® Reagent (GibcoBRL®) and was used for first-strand cDNA synthesis with 
random primers using SuperScriptTM II RNase H- Reverse Transcriptase (GibcoBRL®), 
according to the manufacturer’s instructions. The cDNA encoding the complete human 
Rad9 coding sequence (amino acids 1-391) (6) was then amplified by PCR with a Pfx 
DNA polymerase (GibcoBRL®) using the following primers: 5’ sense, 
5’-TTGGATCCATATGAAGTGCCTGGTCACGGGC-3’; 3’ antisense, 
5’-ATGGATCCCTCAGCCTTCACCCTCACTGTCT-3’. The amplified PCR products 
were digested with BamHI and subcloned into pAS2. Both the coding sequence of Rad9 
and the junction sequences between pAS2 and Rad9 were confirmed by sequencing 
using the Thermo SequenaseTM II dye terminator cycle sequencing premix kit 
(Amersham Pharmacia Biotech). For yeast two-hybrid screening, a human lymphocyte 
cDNA library in pACT (Clontech) was transformed into S. cerevisiae CG1945 
containing pAS2-Rad9, according to the user’s manual. The verified positive cDNAs 
were sequenced, and proteins with similar sequences were sought using GenomeNet 
(Kyoto University, Japan). 
Construction of expression plasmids. The cDNA encoding the full-length Tpr2 
(17) (Tpr2/FL, Figure 1A) was amplified by PCR using BglII site-directed primers (5’ 
sense primer, 5’-AATAAGATCTATGGCGGCGACCGAGCCGGAGCT-3’; 3’ antisense 
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primer, 5’-CCCGGAGATCTCTTAGCCAAATTGAAAAAAGAAAT-3’). The cDNA 
encoding the N-terminal portion of Tpr2 (containing the tpr motifs but lacking the J 
domain) (Tpr2/ΔJ, Figure 1A) was isolated by two-hybrid screening as described above. 
These cDNAs were digested and subcloned into pFlag-CMV-2 (Kodak) at BamHI sites 
to generate pFlag-CMV-Tpr2/FL and pFlag-CMV-Tpr2/ΔJ. A 90-bp NcoI-SmaI 
fragment of pFlag-CMV-2 containing the Flag-tag coding sequence and multiple 
cloning sites was inserted into XbaI (filled in)-digested pEF-Bos to create a Flag-tagged 
expression vector, pEF-Flag. To construct Flag-tagged expression vectors encoding 
various Tpr2 deletion mutants (Figure 2A), the BglII-directed primers described above 
and the following primers were used for PCR: 3’ antisense primer 
(5’-ACCGGATCCATTGGTGGAATCCATTCGTA-3’) for pEF-Flag-Tpr2/5’-motif 
(amino acids 1-199); 5’ sense primer 
(5’-CTTGGATCCGCTCAGGCACAACAAGAGTT-3’) for pEF-Flag-Tpr2/3’-motif 
(amino acids 120-384). These cDNAs were then digested and cloned into pEF-Flag. A 
129-bp XbaI fragment of KSII(+)-3xHA containing the HA-tagged sequence and 
multiple cloning sites was inserted into XbaI-digested pEF-Bos to create the HA-tagged 
expression vector, pEF-3xHA. This plasmid was then used to construct expression 
vectors encoding Tpr2/ΔJ (pEF-3xHA-Tpr2/ΔJ), Tpr2/FL (pEF-3xHA-Tpr2/FL), human 
Rad1 (8) (pEF-3xHA-Rad1) and human Hus1 (pEF-3xHA-Hus1); the human Hus1 
cDNA was cloned by two hybrid screening as described above. HA-tagged expression 
plasmids encoding the entire Rad9 coding sequence (amino acids 1-391) and various 
Rad9 deletion mutants (Figure 3A) were constructed using the following primers: 5’ 
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sense, 5’-AATGGATCCATGAAGTGCCTGGTCACGGGC-3’(starts at amino acid 1); 
3’ antisense, 5’-ATGGATCCCTCAGCCTTCACCCTCACTGTCT-3’(ends at amino 
acid 391); 5’ sense, 5’-AATAGATCTCCCTTGGAGGACGGGCTC-3’(starts at amino 
acid 31); 3’ antisense, 5’-AAAGATCTGGCTTTGGCAGTGCTGTCTGCCT-3’(ends at 
amino acid 192); 5’ sense, 
5’-ACCGGATCCATGGTGACTGAGATGTGCCTT-3’(starts at amino acid193); 
5’-sense, 5’-AATGGATCCTCCCTGCAGGCCGTCTTCGAC-3’ (starts at amino acid 
131).  
Site-directed mutagenesis was performed using a two-round PCR method. In the 
first set of reactions, the partial 5’ and 3’ fragments of the Tpr2HPD mutant (Figure 1A) 
were amplified with the BglII site-directed outside primers (5’ sense, 
5’-AATAAGATCTATGGCGGCGACCGAGCCGGAGCT-3’; 3’antisense, 
5’-CCCGGAGATCTCTTAGCCAAATTGAAAAAAGAAAT-3’) and the overlapping 
inside primers encoding the H399Q mutation (underlined in the primers) (5’-sense, 
5’-GCCTTGATGCACCAACCAGATCGGCATAGT-3’; 3’ antisense, 
5’-TCCACTATGCCGATCTGGTTGGTGCATCAA-3’). The PCR products were 
purified and mixed in equimolar concentrations, then used as templates for the second 
round of PCR amplification with the outside primers described above, and finally 
subcloned into pEF-Flag and pEF-3xHA expression vectors. Sequence analysis 
confirmed that there were no unintentional PCR-introduced mutations. The expression 
vector encoding HA-tagged JNK1 (pEF-3xHA-JNK1) was described previously (25). 
 Co-immunoprecipitation and immunoblotting. Cos7 cells were grown in  
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Dulbecco's Modified Eagle's Medium (DMEM, Gibco-BRL, Life Technologies) 
supplemented with 10% heat inactivated fetal calf serum (FCS, Gibco-BRL), 50 
units/ml of penicillin G and 50 μg/ml streptomycin sulfate (Gibco-BRL) in a 5% CO2 
humidified incubator. The cells were transiently transfected with 15 μg of various 
expression vectors as indicated in the Figures, using the DEAE-dextran method. At 36 
hrs after transfection, cells were harvested, spun down and lysed in 0.5 ml of lysis 
buffer [50 mM HEPES (pH 7.5), 150 mM NaCl, 1% NP-40, 10% glycerol, 2 mM 
MgCl2, 1 mM EGTA, 20 mM β-glycerophosphate, 2 mM Na3VO4, 1 mM 
phenylmethylsulfonyl fluoride, 0.2 mM dithiothreitol]. The debris was then discarded 
after centrifugation at 12,000 rpm for 15 min at 4˚C. The whole-cell lysate was assayed 
for protein quantity, using a Bio-Rad protein assay kit. For co-immunoprecipitation, 1 μl 
of mouse anti-Flag M5 antibodies at 3.4 μg/μl (Sigma) was added to 1.5 mg of cell 
lysate, and the mixtures were then rotated for 2 hrs at 4˚C; then 20 μl of a 50% slurry of 
Protein G-sepharose beads was added and the mixtures were rotated for 2 more hrs at 
4˚C. The beads were washed with lysis buffer four times, then resuspended in SDS 
sample buffer and boiled 5 min. Mouse anti-Flag M5, rat high-affinity anti-HA 
(Boehringer Mannheim), or rabbit anti-human Rad9 antibodies were used as the first 
antibodies for western blotting at a 1:2000 dilution; Horse anti-mouse IgG (H&L [heavy 
and light chains]) HRP-linked (New England Biolabs), goat anti-rat IgG (H&L) 
HRP-linked (Funakoshi), or goat anti-rabbit IgG (H&L) HRP-linked (Funakoshi) 
antibodies were used as second antibodies at a 1:4000 dilution. Rabbit anti-human Rad9 
antibody was kindly provided by S. P. Jackson (The WellcomeCRC Institute, University 
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of Cambridge). 
In vitro protein binding assay. The complete Rad9 (amino acids 1-391), Rad1 
(amino acids 1-282) and Hus1 (amino acids 1-280) cDNAs were subcloned into the 
BlueScript vector for in vitro translation. To generate glutathione-S-transferase 
(GST)-Tpr2 fusion proteins, the cDNA encoding Tpr2/FL (amino acids 1-484) or the 
Tpr2/ΔJ fragment (amino acids 1-384) was subcloned into pGEX-4T-3 (Amersham 
Pharmacia Biotech). GST fusion proteins were induced with 0.2 mM 
isopropyl-beta-D-thiogalactopyranoside (Sigma) and purified from host E. coli 
XL1-Blue at 30˚C using glutathione-conjugated agarose beads (Amersham Pharmacia 
Biotech). Rad9, Rad1 and Hus1 were transcribed and translated in vitro in the presence 
of [35S]-methionine using Rabbit Reticulocyte Lysate (Promega) according to the 
manufacturer’s instructions. Ten micrograms of GST, GST-Tpr2/FL, or GST-Tpr2/ΔJ 
attached to glutathione-conjugated agarose beads were mixed with 25 μl of the lysate 
containing translated proteins in binding buffer (50 mM HEPES/KOH, pH 7.5, 100 mM 
KOAc, 5 mM Mg(OAc)2, 5 mM DTT, 10% glycerol, 1% NP-40, 1 mM 
phenylmethylsulfonyl fluoride). After 1 hr of rotation at room temperature, the beads 
were recovered and washed, then resuspended in SDS sample buffer and fractioned by 
SDS-PAGE followed by autoradiography. 
Immunofluorescence. To establishMCF-7 cell lines that stably express Flag-tagged 
full-length Tpr2 or HPD mutant Tpr2 proteins, linearized plasmids (pSV2-neo and 
pFlag-CMV2-Tpr2/FL or pEF-Flag-Tpr2/HPD mutant, at the molar ratio of 1 to 20) 
were transfected into MCF-7 cells (25 μg of DNA/5x106 cells) by electroporation (220 
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mV, 960 μF). After two weeks of G418 (400 μg/ml, Nacalai Tesque) selection, 
G418-resistant clones were analyzed for Tpr2 protein expression. The parental MCF-7 
cells and stable transfectant lines were plated on cover slips and grown to 30% 
confluence. They were then transiently transfected with pEF-3xHA-Rad9 using 
DOSPER liposomal transfection reagents (Roche). Twenty hours after transfection, the 
cells were washed twice with PBS, fixed in 3% paraformaldehyde/PBS, and 
permeabilized by 0.1% NP-40/PBS for 20 minutes. Cells were blocked for 40 minutes 
in 1% bovine serum albumin in PBS containing 0.1% Tween-20, and incubated 2 hrs 
with rat high-affinity anti-HA or mouse anti-Flag M5 antibodies in blocking buffer. 
Finally, immune complexes were stained with Rhodamine-conjugated anti-Rat IgG or 
FITC-conjugated anti-Mouse IgG antibodies. Stained cells were analyzed using a Zeiss 
LSM510 laser-scanning confocal microscope.  
 
Results 
Identification of Tpr2 as a Rad9-binding factor by two-hybrid screening 
Using a pACT-packaged human lymphocyte cDNA library and the entire human 
Rad9 coding sequence in pAS2 as bait, we sequentially screened approximately 1 x 107 
cotransformants of S. cerevisiae CG1945 for proteins that directly interact with Rad9. 
Of 90 His+ clones, 47 LacZ+ clones were chosen for further study. After plasmid rescue, 
these clones were digested by EcoRI and XhoI and sorted into four groups. 
Bait-dependent binding was confirmed within two of the groups: one large group 
containing 40 clones and another containing 4 clones. Within each group, at least two 
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clones were randomly selected for sequence analysis and protein homology search. We 
found that the insert in the large group encoded Hus1 and the insert in the small group 
encoded Tpr2. Although the interaction of human Rad9 with human Hus1 was 
demonstrated previously (26-28), the interaction of Rad9 with Tpr2 had not been 
reported. 
  The Tpr2 cDNA that we isolated from the two-hybrid screening did not contain 
the entire Tpr2 coding sequence; rather, it contained the sequence from nucleotide 7 to 
nucleotide 1753 of the full-length Tpr2 cDNA (17). Furthermore, the nucleotide 
sequence 1149-1408 was deleted, thus generating a new stop codon, with the deduced 
amino acid sequence stopping at amino acid 384 (Fig. 1A). We named this protein 
Tpr2/ΔJ, because it does not contain the C-terminal J domain but still contains all seven 
of the N-terminal tpr motifs. Because there were no typical GU·········AG conserved 
sequences near the deleted portion of the Tpr2 cDNA, and because we could not detect 
Tpr2/ΔJ expression in many different types of cell lines (data not shown), it is unlikely 
that Tpr2/ΔJ is a splicing variant of Tpr2. 
The J domain of Tpr2 modulates interactions with Rad9 but not with Hus1 and 
Rad1  
To confirm that Tpr2 binds to Rad9 in vivo as well as in vitro, we performed 
co-immunoprecipitation and GST pull-down experiments. Because Rad9 can form 
stable complexes with Hus1 and Rad1 (13, 26-28), these binding analyses were also 
performed for Hus1 and Rad1. For the in vivo binding experiments, we transiently 
cotransfected Cos7 cells with HA-tagged expression vectors encoding Rad9, Hus1, or 
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Rad1 with Flag-tagged expression vectors encoding either Tpr2/ΔJ or Tpr2/FL (Fig. 1A). 
As shown in Figure 1B and 1C, immunoprecipitation of Tpr2/ΔJ or Tpr2/FL with an 
anti-Flag (M5) antibody brought down, not only the HA-tagged Rad9, but also the 
HA-tagged Hus1 and Rad1, indicating that the N-terminal tpr region of Tpr2 binds these 
proteins. However, the Tpr2/ΔJ protein, lacking the J domain, showed much stronger 
binding to Rad9 than did the full-length Tpr2 protein (Tpr2/FL) (compare lane 2 in Fig. 
1B and Fig. 1C). Furthermore, the binding patterns of Tpr2/ΔJ and Tpr2/FL with Hus1 
or Rad1 were similar, indicating that the J domain influences only the interaction 
between Tpr2 and Rad9.  
To further study the effect of the J domain on the Tpr2/Rad9 interaction, we 
introduced a point mutation in the conserved HPD motif of the Tpr2 J-domain (HPD 
mutant, Figure 1A). As shown in Figure 1D, the HPD mutant of Tpr2 also showed very 
strong binding to Rad9 (actually stronger than that of Tpr2/ΔJ). These results indicate 
that, while the N-terminal tpr region of Tpr2 are binding sites for Rad9, the J domain 
plays a critical role in the interaction between Rad9 and Tpr2 in vivo. Consistent with 
these in vivo results, in vitro binding analysis showed that GST-Tpr2/ΔJ also bound to 
the Rad9 protein translated in vitro by rabbit reticulocyte lysates more effectively than 
did GST-Tpr2/FL (Figure 1E, lanes 3 and 5). We further found that GST-Tpr2/ΔJ and 
GST-Tpr2/FL bound similarly to Rad1 and Hus1 (data not shown), again supporting a 
specific role for the J domain in the Tpr2/Rad9 interaction. In addition, the inclusion of 
ATP in the Mg2+-containing binding buffer inhibited the binding of Rad9 to 
GST-Tpr2/FL, but not to GST-Tpr2/ΔJ (Figure 1E, lanes 3-6). Because J domains 
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function as co-chaperones for chaperones such as Hsp70, which utilize ATP hydrolysis 
for their function (21), the results of these binding experiments suggest that the 
Tpr2/Rad9 interaction is regulated by the Tpr2-J-domain’s co-chaperone activity, 
presumably together with major chaperones such as Hsp70.  
Binding site mapping for the Tpr2/Rad9 interaction 
The results shown in Figures 1 indicated that the N-terminal tpr region of Tpr2 were 
the primary binding sites for Rad9. Tpr2 contains seven tpr motifs; therefore, we 
constructed expression vectors encoding the N-terminal and C-terminal parts of these 
tpr motifs (Figure 2A) to further define the binding sites in Tpr2 for Rad9, Hus1, and 
Rad1 as well as for Tpr2 itself. Expression vectors encoding these tpr motif mutants 
were transfected into Cos7 cells and the binding activity of these mutants for Rad9, 
Hus1, Rad1, and Tpr2 was examined by co-immunoprecipitation experiments. As 
shown in Figure 2B, the 5’-motif of Tpr2 (amino acids 1-199), containing the three 
N-terminal tpr motifs, is sufficient to support binding to Rad9. While these N-terminal 
tpr motifs of Tpr2 appeared to be important for Rad1 binding as well, both the 
N-terminal and C-terminal tpr motifs and even the J domain appeared to be required for 
Hus1 binding and Tpr2 homodimerization (Figure 2B).  
Rad9 contains three functional regions (Figure 3A): (1) the N-terminal BH3-like 
region, which may have proapoptotic functions similar to the BH3 domains conserved 
in Bcl-2 family members (15); (2) the 3’ to 5’exonuclease (3’ to 5’)-like region, which 
may be involved in DNA damage repair (10); and (3) the C-terminal Rad1- and Hus1- 
binding region (28). To define the binding sites for Tpr2 in Rad9, expression vectors 
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encoding various parts of Rad9 (Figure 3A) were transfected and 
co-immunoprecipitation experiments were carried out. The results shown in Figure 3B 
indicate several unique features of Rad9. Firstly, Rad9 was mainly phosphorylated in its 
C-terminal Rad1/Hus1 binding region (lanes 2-5). Secondly, the N-terminal BH3-like 
region was dispensable for Tpr2 binding, but its deletion enhanced the binding of Rad9 
to the wild-type Tpr2 (lanes 11 and 12). Finally, both of the non-overlapping N-terminal 
(amino acids 1-192, 3’-del) and C-terminal (amino acids 193-391, C-terminal) regions 
of Rad9 bound to Tpr2 (lanes 2 and 4). However, while the wild-type (FL) and HPD 
mutant Tpr2 bound equally to the N-terminal region of Rad9 (amino acids 1-192, 
3’-del) (lanes 4 and 10), the C-terminal regions of Rad9 (amino acids 131-391, 5’-del; 
amino acids 193-391, C-terminal) could only bind to the HPD mutant of Tpr2 (lanes 2, 
3, 8, and 9). 
Functional links between Rad9 and Tpr2 
Because Hsp70 was implicated as a possible cofactor in the J-domain-dependent 
interaction between Tpr2 and Rad9 (Figure 1E) and because it is a major heat-inducible 
protein, we hypothesized that heat-shock treatment would modulate the interaction 
between Tpr2 and Rad9. To test this hypothesis, Cos7 cells were cotransfected with 
HA-tagged Rad9 expression vectors and Flag-tagged expression vectors encoding the 
wild-type (FL) and HPD mutant of Tpr2, and subjected to heat shock treatment (at 43˚C 
for 60 minutes). Tpr2/Rad9 binding was then analyzed by co-immunoprecipitation. As 
shown in Figure 4, while the HPD mutant of Tpr2 continued to bind strongly to Rad9 
after heat-shock treatment (lanes 6-10), Rad9 became transiently dissociated from the 
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wild-type Tpr2 (lanes 1-5). These results indicate that the Rad9/Tpr2 interaction is 
modulated in cellular responses to stress, such as heat-shock, in a J-domain-dependent 
manner. 
To study further possible functional links between Rad9 and Tpr2, we established 
MCF-7 cell lines that stably expressed the wild-type (FL) and HPD mutant of Tpr2. The 
parental MCF-7 cells and stable cell lines were transiently transfected with HA-tagged 
Rad9 expression vectors and the cellular localization of transiently expressed Rad9 as 
well as of stably expressed the wild-type and HPD mutant of Tpr2 was then analyzed by 
immuno-fluorescence confocal microscopy. Previous studies disagreed about the exact 
cellular location of Rad9. Two studies showed Rad9 to be exclusively localized to the 
nucleus (27, 29), whereas a third study showed Rad9 to be located throughout the cell, 
but concentrated in the nucleus and partially overlapping with Bcl-2 on the intracellular 
membranes (15). As shown in Figure 5 (upper panels), we observed Rad9 to be almost 
exclusively localized to the nucleus in parental MCF-7 cells. However, in MCF-7 cells 
stably over-expressing Tpr2/FL, Rad9 was located in the cytoplasm as well as in the 
nucleus and was co-localized with Tpr2/FL in these cellular compartments (middle 
panels, Figure 5). Interestingly, the HPD mutant of Tpr2 was mainly localized to the 
nucleus, and Rad9 in these cells was again co-localized with the HPD mutant of Tpr2, 
mainly in the nucleus (lower panels, Figure 5). These results indicate that the J domain 




In an attempt to further characterize Rad9 functions in cell-cycle checkpoint as well 
as apoptotic control, we identified Tpr2 as a novel Rad9-binding protein. The results of 
in vitro GST pulldown and co-immunoprecipitation assays indicated that Tpr2 binds, 
not only to Rad9, but also to other Rad9 partners such as Rad1 and Hus1, through its 
N-terminal tpr motifs. However, deletion of the C-terminal J domain of Tpr2 or a point 
mutation in the conserved HPD motif in the J domain strongly enhanced the in vivo 
interaction of Tpr2 with Rad9, but not with Rad1 or Hus1 (Figure 1), indicating that the 
interaction between Tpr2 and Rad9 is regulated by the J domain of Tpr2. In vitro 
binding experiments further showed that ATP inhibits the binding of Tpr2 to Rad9 
(Figure 1E). The J domains of the Hsp40/DnaJ family are known to regulate the 
chaperone activity of Hsp70/Hsc70 through stimulation of their intrinsic ATPase 
activity (21), and Tpr2 has been shown to bind to Hsc70 through its N-terminal tpr 
motifs (20). These findings suggest that Tpr2 acts as a co-chaperone for the 
Hsc70/Hsp70 chaperones.  
Rad9 contains two Tpr2-binding sites. While the in-vivo interaction of Tpr2 with the 
N-terminal part of Rad9 is not influenced by the Tpr2’s J domain, the interaction of 
Tpr2 with the C-terminal part of Rad9, which is mainly phosphorylated in vivo, is very 
strongly enhanced by a point mutation in the conserved HPD motif in the J domain 
(Figure 3B). This raises an interesting possibility that Rad9 phosphorylation plays an 
important role in the interaction between Rad9 and Tpr2. However, it is unlikely that 
Rad9 phosphorylation itself is critical for the J domain-dependent interaction between 
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Tpr2 and Rad9, because the in vitro translated and unphosphorylated C-terminal region 
of Rad9 also showed an enhanced binding to the Tpr2 protein lacking the J domain 
(unpublished data). Further work is required to define precise functional roles for these 
two non-overlapping Tpr2-binding regions of Rad9 in the interaction between Rad9 and 
Tpr2. 
To explore possible functional interactions between Tpr2 and Rad9, we studied Rad9 
localization in MCF-7 cells that overexpressed either wild-type Tpr2 or Tpr2 with a 
point mutation in the conserved HPD motif. We found Rad9 to be almost exclusively 
localized in the nucleus of parental MCF-7 cells. However, Rad9 was located in both 
the cytoplasm and nucleus in MCF-7 cells that stably over-expressed the wild-type Tpr2, 
and was co-localized with Tpr2 in these cellular compartments. Interestingly, the point 
mutation in the HPD motif resulted in the redistribution of Tpr2 mainly to the nucleus, 
and Rad9 was again co-localized with the HPD mutant of Tpr2, mainly in the nucleus 
(Figure 5). We also studied the in vivo Tpr2/Rad9 interaction after treatment with 
noxious stimuli such as heat-shock (Figure 4) or UV radiation (data not shown). We 
found that, while Rad9 transiently dissociated from Tpr2 following these treatments, the 
HPD mutation abolished this transient dissociation of the Tpr2/Rad9 complex. These 
results therefore indicated that the J domain of Tpr2 plays a critical role in the 
regulation of both the cellular localization of Tpr2 and Rad9 and the complex formation 
between them. 
Here we presented evidence for physical and functional interactions between Tpr2 
and Rad9 and for their regulation by the J domain of Tpr2. Although genetically 
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identified as one of key molecules acting in the early phase of cell-cycle checkpoint 
control, the precise biochemical functions of Rad9 remain to be established. Because 
Rad9, Rad1 and Hus1 show a structural similarity to PCNA (11-13) and because these 
three molecules, whether derived from S. pombe (13) or human (26-28), form a 
tri-molecular complex, it has been postulated recently that they function as a PCNA-like, 
DNA-sliding clamp complex, coupling DNA repair and DNA synthesis to cell cycle 
checkpoint control (11-13). In addition, recent studies showed that human and S. pombe 
Rad9 contains a BH3-like sequence in its N terminus that is conserved among members 
of the Bcl-2 apoptotic family and that Rad9 interacts with Bcl-2 through this BH3 motif 
(15, 16). Furthermore, over-expression of the Rad9 gene from either organism in human 
cells can cause apoptosis in a BH3-motif-dependent manner (15). On the other hand, the 
physiological functions of Tpr2 are not clear, although Tpr2 has structural properties 
characteristic of co-chaperones (17, 22). To explore further possible physiological 
implications, we studied the effects of wild-type or mutant Tpr2 over-expression on the 
interactions of Rad9 with Rad1 or Hus1, but have not observed any significant effects 
so far (unpublished data). However, while cells that stably over-expressed wild-type 
Tpr2 were more resistant to the apoptosis induced by UV radiation or heat-shock, cells 
that over-expressed Tpr2 containing a point mutation in the conserved HPD motif in the 
J domain showed enhanced spontaneous apoptosis as well as enhanced apoptosis 
induced by UV radiation or heat-shock (unpublished data). This observation suggests 
that Tpr2 modulates stress-induced apoptosis through its interaction with Rad9. Since 
recent studies have shown that Hsp70 negatively regulates several steps in apoptotic 
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pathways that are initiated by diverse stimuli (30-33), it is further possible that Tpr2 
functions to co-operate with Hsp70/Hsc70 in this apoptotic regulation. Further work is 
required to define the observed effects of Tpr2 on apoptosis. 
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Figure 1  Tpr2 binds to Rad9 in vivo and in vitro.  
(A) Schematic diagram of Tpr2 and its mutants. Tpr2 contains seven tpr motifs and the J 
domain, as indicated. (B, C) Cos7 cells at 40% confluence in 10-cm dishes were 
transiently co-transfected with 15 μg of pFlag-CMV2-Tpr2/ΔJ (B) or 
pFlag-CMV2-Tpr2/FL (C) and 15 μg of pEF-3xHA-Rad9 (lanes 2, 6, and 10), 
pEF-3xHA-Hus1 (lanes 3, 7, and 11), or pEF-3xHA-Rad1 (lanes 4, 8, and 12), as 
indicated; pEF-3xHA-JNK1 (lanes 1, 5, and 9) was used as a control. Thirty-six hours 
after transfection, cellular lysates were immunoprecipitated with anti-Flag antibodies, 
and the immunoprecipitates were subjected to immunoblot analysis using anti-HA 
antibodies (IP, lanes 1-4). To check protein expression levels, 10% of the cellular lysates 
were directly subjected to immunoblot analysis (IB) using either anti-HA antibodies 
(lanes 5-8) or anti-Flag antibodies (lanes 9-12). Rad9, Hus1, Rad1, and JNK1 are 
indicated by the star. (D) Flag-tagged expression vectors encoding wild-type Tpr2 (FL: 
lanes 1, 4, and 7), the HPD mutant of Tpr2 (lanes 2, 5, and 8), or JNK1 (lanes 3, 6, and 
9) were cotransfected with HA-tagged Rad9 expression vectors. Cellular lysates were 
immunoprecipitated with anti-Flag antibodies, followed by immunoblot analysis using 
anti-HA antibodies (IP, lanes 1-3). Protein expression levels were checked by 
immunoblotting (IB) with anti-HA (lanes 4-6) or anti-Flag (lanes 7-9) antibodies. (E) 
Rad9 was translated in vitro using rabbit reticulocyte lysates in the presence of 
[35S]-methionine. Translated proteins were incubated with either GST (lanes 1 and 2), 
GST-Tpr2/ΔJ (lanes 3 and 4), or GST-Tpr2/FL (lanes 5 and 6) proteins attached to 
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glutathione-conjugated agarose beads in the absence or presence of 5 mM ATP, as 
indicated. 
Figure 2  Binding analysis of Tpr2 deletion mutants.   
(A) Schematic diagram of Tpr2 and various truncated mutants of Tpr2 used for the 
in-vivo binding assay. (B) Flag-tagged expression vectors encoding various Tpr2 
mutants were cotransfected with HA-tagged expression vectors encoding Rad9, Rad1, 
Hus1, or Tpr2, as indicated. Co-immunoprecipitation was carried out with anti-Flag 
antibodies, followed by immunoblot analysis with anti-Rad9 or anti-HA antibodies (IP). 
Protein levels were checked by immunoblot analysis (IB). 
Figure 3  Binding analysis of Rad9 deletion mutants.   
(A) Schematic diagram of Rad9 and various truncated mutants of Rad9 used for the in 
vivo binding assay. (B) HA-tagged expression vectors encoding various Rad9 deletion 
mutants were cotransfected with Flag-tagged expression vectors encoding either the 
HPD mutant (lanes 2-6) or wild-type (FL, lanes 8-12) Tpr2, as indicated. HA-tagged 
JNK1 expression vectors were used as the negative control (lanes 1 and 7). The upper 
panel shows the results of the co-immunoprecipitation (IP). The middle and lower 
panels (immunoblot, IB) show the protein expression levels of Rad9, Tpr2, and JNK1.  
Figure 4  Rad9 transiently dissociates from Tpr2 after heat-shock.   
Thirty-six hours after cotransfection with Rad9 expression vectors and expression 
vectors encoding the wild-type (FL, lanes 1-5) or HPD mutant (lanes 6-10) Tpr2, Cos7 
cells were exposed to heat-shock treatment (at 43˚C for 60 min). Following treatment, 
fresh medium was added for extended incubation as indicated and cellular lysates were 
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prepared for co-immunoprecipitation experiments (IP, upper panel). The middle and the 
lower panels (immunoblot, IB) show the protein expression levels of Rad9 and Tpr2, 
respectively. 
Figure 5  The J domain-dependent colocalization of Rad9 and Tpr2.   
MCF-7 cells (upper panel) and transfectants that stably expressed either 
Flag-Tpr2/FL (middle panel) or the Flag-Tpr2/HPD mutant (lower panel) were 
transiently transfected with HA-Rad9 expression vectors. Twenty hours after 
transfection, cells were reacted with anti-Flag or anti-HA antibodies, followed by 
staining with Rhodamine (Rad9, red)- or FITC (Tpr2, green)-conjugated secondary 
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